Acquisition by Rock Edwin of 115000 shares of GlycoMimetics at 0.2671 subject to Rule 16b-3
| GLYC Stock | USD 0.29 0.01 3.57% |
About 55% of GlycoMimetics' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding GlycoMimetics suggests that some traders are interested. The current market sentiment, together with GlycoMimetics' historical and current headlines, can help investors time the market. In addition, many technical investors use GlycoMimetics stock news signals to limit their universe of possible portfolio assets.
GlycoMimetics |
Filed transaction by GlycoMimetics Officer: Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
GlycoMimetics Fundamental Analysis
We analyze GlycoMimetics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlycoMimetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GlycoMimetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
GlycoMimetics is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
GlycoMimetics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GlycoMimetics stock to make a market-neutral strategy. Peer analysis of GlycoMimetics could also be used in its relative valuation, which is a method of valuing GlycoMimetics by comparing valuation metrics with similar companies.
Peers
GlycoMimetics Related Equities
| ASMB | Assembly Biosciences | 6.63 | ||||
| CUE | Cue Biopharma | 4.93 | ||||
| ANTX | AN2 Therapeutics | 4.67 | ||||
| BCAB | Bioatla | 4.55 | ||||
| TRVI | Trevi Therapeutics | 1.50 | ||||
| SPRO | Spero Therapeutics | 1.23 | ||||
| IVA | Inventiva | 1.21 | ||||
| MLYS | Mineralys Therapeutics, | 0.39 | ||||
| FHTX | Foghorn Therapeutics | 0.49 | ||||
| ACHL | Achilles Therapeutics | 0.72 | ||||
| DYN | Dyne Therapeutics | 1.00 | ||||
| TIL | Instil Bio | 3.52 |
Complementary Tools for GlycoMimetics Stock analysis
When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |